P1.02-083 Gene Fusion Profile in Lung Adenocarcinoma Patients in Brazil
نویسندگان
چکیده
منابع مشابه
SEC31A-ALK Fusion Gene in Lung Adenocarcinoma
Anaplastic lymphoma kinase (ALK) fusion is a common mechanism underlying pathogenesis of non-small cell lung carcinoma (NSCLC) where these rearrangements represent important diagnostic and therapeutic targets. In this study, we found a new ALK fusion gene, SEC31A-ALK, in lung carcinoma from a 53-year-old Korean man. The conjoined region in the fusion transcript was generated by the fusion of SE...
متن کاملGene Regulation Network Based Analysis Associated with TGF-beta Stimulation in Lung Adenocarcinoma Cells
Background: Transforming growth factor (TGF)-β is over-expressed in a wide variety of cancers such as lung adenocarcinoma. TGF-β plays a major role in cancer progression through regulating cancer cell proliferation and remodeling of the tumor micro-environment. However, it is still a great challenge to explain the phenotypic effects caused by TGF-β stimulation and the effect of TGF-β stimulatio...
متن کاملMEK1 gene mutation in Japanese lung adenocarcinoma patients.
Recently, to identify potential somatic mutations in genes of the epidermal growth factor receptor (EGFR) signaling pathway, the MEK1 gene mutation at exon 2 was identified. The mutant form of MEK1 leads to the constitutive activity of extracellular signal-regulated kinase (ERK)-1/2. We investigated MEK1 gene mutation status in 241 surgically treated lung adenocarcinoma cases from Nagoya City U...
متن کاملClinicopathological Profile of Lung Cancer Patients in a Teaching Hospital in South India
Introduction: Lung cancer is one of the leading causes of cancer related deaths in the world. The incidence of lung cancer is increasing in India and there is a need to understand the natural history of this disease. Aim of the study: To study the clinico- pathological- radiological profile of patients diagnosed with lung cancer from January 2013 to May 2015 at a tertiary care teaching hospital...
متن کاملPre-Treatment Serum CEA and EGFR Mutations and EML4-ALK Fusion Gene in Lung Adenocarcinoma
Lung cancer is the most common cause of cancerrelated deaths, where it is associated with a 5-year worldwide survival rate of less than 15% (Jemal et al., 2011). Among new diagnoses of pulmonary carcinoma, Non-small-cell lung cancer (NSCLC) accounts for approximately 80% (Ozgul et al., 2013). Despite great efforts to improve the survival of patients with NSCLC, the outcomes are still considered...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2017
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2016.11.667